|
|
|
Corporate Profile: Regenerx
Biopharmaceuticals
| Summary: |
Regenerex Biopharmaceutcials
is involved in the development and commercialization
of Thymosin ßeta 4 (Tß4), to heal chronic wounds caused
by disease, abrasion, or other related conditions. |
| Address: |
3 Bethesda Metro Center
Suite 700
Bethesda, MD 20814 |
| Phone
#'s: |
Main |
(301) 280-1992 |
| Human Resources |
not known |
| Investor Relations |
not known |
| Fax
#'s: |
Main |
(301) 280-1996 |
| Human Resources |
not known |
| Investor Relations |
not known |
| Financial
information: |
| RGN |
| Internet
job postings: |
| not
known |
| Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
